August 7, 2018
Rare Revolution Magazine
“For many in the rare and difficult-to-diagnose disease space, an earlier diagnosis is the difference between a family facing the challenges of their child’s health with a community of support and stepping into the unknown, alone.”
The article focuses on FDNA’s groundbreaking efforts to address undiagnosed diseases through its advanced technology platform, Face2Gene. FDNA utilizes artificial intelligence to analyze facial features and identify patterns indicative of rare genetic disorders, offering a lifeline to patients struggling with undiagnosed diseases. The platform empowers healthcare professionals to achieve faster and more accurate diagnoses, thus facilitating early intervention and personalized treatment plans. The article highlights the transformative impact of FDNA’s technology in bringing hope and clarity to patients and families navigating the challenges of rare and undiagnosed medical conditions.
